The latest in collection, detection, assessment and monitoring of drug safety data
What to look for in a partner to support biosimilar initiatives
This article looks at some of the trends in biosimilars, including three key errors you need to avoid. Particularly, as it pertains to underestimating your risk management plan.
The Importance of QPPVs in Pharmacovigilance
Ian Kovacs, Head of QPPV & Safety Consulting at PAREXEL answers five key questions about the key role of a QPPV and why you should consider outsourcing.
A real life pharmacovigilance case story
How to implement a flexible and scalable pharmacovigilance model to transition a product from one company to another.
Safety Reporting in Clinical Trials